In the CNS, Axl and Mertk are mainly expressed in microglia, and their loss leads to enhanced inflammation in the CNS and delayed removal of myelin debris in experimental models of MS (Ray et al., 2017; O'Guin et al., 2014). The gene discussed is AXL; the disease is myeloid sarcoma.